1. Home
  2. DKI vs DCOY Comparison

DKI vs DCOY Comparison

Compare DKI & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DKI

DarkIris Inc. Class A Ordinary Shares

N/A

Current Price

$1.56

Market Cap

718.2K

Sector

N/A

ML Signal

N/A

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$1.10

Market Cap

674.8K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DKI
DCOY
Founded
2018
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
718.2K
674.8K
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
DKI
DCOY
Price
$1.56
$1.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 14.5M
74.1K
Earning Date
08-13-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.42
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.53
52 Week High
$9.13
$67.68

Technical Indicators

Market Signals
Indicator
DKI
DCOY
Relative Strength Index (RSI) 50.52 33.76
Support Level $0.29 $0.53
Resistance Level $2.43 $3.29
Average True Range (ATR) 0.21 0.11
MACD 0.24 0.06
Stochastic Oscillator 63.21 32.71

Price Performance

Historical Comparison
DKI
DCOY

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: